Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study".
Int J Impot Res
; 36(3): 297-298, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38519589
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Int J Impot Res
Journal subject:
MEDICINA REPRODUTIVA
/
UROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Dinamarca